Christopher K. Daugherty

Christopher Daugherty practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Christopher Daugherty's NPI, 1063574523, was assigned on December 14, 2006. Christopher Daugherty graduated from Indiana University School of Medicine in 1989. Christopher Daugherty holds Illinois license 036087565.

Christopher Daugherty's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Christopher Daugherty's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Christopher Daugherty is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Christopher Daugherty to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Daugherty practices. Vendor and product names are available with a free account.

Hematology and oncology is Christopher Daugherty's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Christopher Daugherty is licensed in Illinois.

CMS data shows 268 Medicare services from Christopher Daugherty across 6 procedure codes in 2024, for 123 Medicare patients. Medicare paid $26,524 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Christopher Daugherty in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Daugherty's median patient age at 69, with 62% women.

In 2024, Christopher Daugherty wrote 439 Medicare Part D claims for 42 patients. 66% of them were for generic drugs. CMS names the drug for 306 of them, across 15 drugs with 11 or more claims each, at $1,670,062 in total drug cost. In 2023, CMS named 223 claims across 10 drugs.

Christopher Daugherty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Daugherty as offering telehealth.

Dmand AI links 28 papers to Christopher Daugherty, published from 2011 to 2025. 2016 was the busiest year, with 4. The most frequent topics are Decision Making, Medical Oncology and Practice Patterns, Physicians'. Christopher Daugherty has published most often in JCO Oncol Pract. Christopher Daugherty's most frequent co-authors are David F. Cella, PhD, Lucy Ann Godley and Andrew Hantel, MD.

Dmand AI links Christopher Daugherty to 1 clinical trial. Conditions studied include Bile Duct Neoplasms and Mesothelioma, Malignant.

CMS Open Payments shows 2 general payments to Christopher Daugherty from 1 drug or device company from 2018 to 2021. Consulting fees make up the largest share, 100% of the total. Daiichi Sankyo Inc. paid the most, $18,340.

Christopher Daugherty graduated from Indiana University School of Medicine in 1989.